$LCID
Lucid Group, Inc. Stock $lcid

$lcid Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000162828022012681 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$57.68M	$313.0K
YoY Change	18326.52%
Cost Of Revenue	$246.0M	$85.00K
YoY Change	289276.47%
Gross Profit	-$188.3M	$228.0K
YoY Change	-82685.53%
Gross Profit Margin	-326.48%	72.84%
Selling, General & Admin	$223.2M	$131.7M
YoY Change	69.51%	827.13%
% of Gross Profit		57742.11%
Research & Development	$186.1M	$167.4M
YoY Change	11.18%	52.43%
% of Gross Profit		73407.46%
Depreciation & Amortization	$38.24M	$4.919M
YoY Change	677.43%	227.93%
% of Gross Profit		2157.46%
Operating Expenses	$409.2M	$299.0M
YoY Change	36.86%	141.15%
Operating Profit	-$597.5M	-$298.8M
YoY Change	99.98%	140.96%
Interest Expense	$7.705M	$5.000K
YoY Change	154000.0%	-100.09%
% of Operating Profit
Other Income/Expense, Net	$516.6M	-$449.2M
YoY Change	-215.01%	449055.0%
Pretax Income	-$80.96M	-$747.9M
YoY Change	-89.18%	476.68%
Income Tax	$300.0K	$4.000K
% Of Pretax Income
Net Earnings	-$81.29M	-$748.0M
YoY Change	-89.13%	477.12%
Net Earnings / Revenue	-140.94%	-238962.3%
Basic Earnings Per Share	-$0.05	-$89.29
Diluted Earnings Per Share	-$0.36	-$89.29
COMMON SHARES
Basic Shares Outstanding	1.654B shares	32.65M shares
Diluted Shares Outstanding	1.682B shares	32.65M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.392B	$810.5M
YoY Change	565.26%
Cash & Equivalents	$5.392B	$838.0M
Short-Term Investments		$505.0K
Other Short-Term Assets	$95.49M	$51.17M
YoY Change	86.6%
Inventory	$333.9M	$6.310M
Prepaid Expenses	$42.33M
Receivables	$867.0K	$637.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$5.864B	$868.6M
YoY Change	575.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.494B	$899.9M
YoY Change	66.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$43.24M	$31.27M
YoY Change	38.3%
Total Long-Term Assets	$1.537B	$931.2M
YoY Change	65.1%
TOTAL ASSETS
Total Short-Term Assets	$5.864B	$868.6M
Total Long-Term Assets	$1.537B	$931.2M
Total Assets	$7.402B	$1.800B
YoY Change	311.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$66.44M	$9.229M
YoY Change	619.9%
Accrued Expenses	$41.21M	$29.20M
YoY Change	41.14%
Deferred Revenue
YoY Change
Short-Term Debt	$4.399M	$0.00
YoY Change
Long-Term Debt Due	$4.485M	$2.510M
YoY Change	78.69%
Total Short-Term Liabilities	$511.9M	$259.3M
YoY Change	97.42%
LONG-TERM LIABILITIES
Long-Term Debt	$1.988B	$4.244M
YoY Change	46743.71%
Other Long-Term Liabilities	$194.9M	$1.309B
YoY Change	-85.12%
Total Long-Term Liabilities	$2.183B	$1.314B
YoY Change	66.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$511.9M	$259.3M
Total Long-Term Liabilities	$2.183B	$1.314B
Total Liabilities	$3.572B	$1.573B
YoY Change	127.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.100B
YoY Change
Common Stock	$167.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$20.72M
YoY Change
Treasury Stock Shares	857.8K shares
Shareholders Equity	$3.829B	-$4.228B
YoY Change
Total Liabilities & Shareholders Equity	$7.402B	$1.800B
YoY Change	311.26%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$81.29M	-$748.0M
YoY Change	-89.13%	477.12%
Depreciation, Depletion And Amortization	$38.24M	$4.919M
YoY Change	677.43%	227.93%
Cash From Operating Activities	-$494.6M	-$218.7M
YoY Change	126.15%	167.03%
INVESTING ACTIVITIES
Capital Expenditures	-$185.1M	-$94.78M
YoY Change	95.28%	-192.82%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$185.1M	-$94.78M
YoY Change	95.28%	-7.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$187.3M	$511.1M
YoY Change	-136.65%	155.55%
NET CHANGE
Cash From Operating Activities	-$494.6M	-$218.7M
Cash From Investing Activities	-$185.1M	-$94.78M
Cash From Financing Activities	-$187.3M	$511.1M
Net Change In Cash	-$867.0M	$197.6M
YoY Change	-538.8%	1136.5%
FREE CASH FLOW
Cash From Operating Activities	-$494.6M	-$218.7M
Capital Expenditures	-$185.1M	-$94.78M
Free Cash Flow	-$309.6M	-$123.9M
YoY Change	149.76%	-32.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001811210
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-39408
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Lucid Group, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0891392
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	7373 Gateway Boulevard
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Newark
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94560
CY2022Q1	dei	City Area Code CityAreaCode	510
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	648-3553
CY2022Q1	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.0001 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	LCID
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q4	us-gaap	Assets Current AssetsCurrent	6506977000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1327544000	USD
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1667840573	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5391844000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6262905000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	867000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3148000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	333906000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	127250000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	42325000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	70346000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	95489000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	43328000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	5864431000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	396101000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6039000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1182153000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	166625000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161974000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43240000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	30609000	USD
CY2022Q1	us-gaap	Assets Assets	7401840000	USD
CY2021Q4	us-gaap	Assets Assets	7881713000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	66440000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	41342000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28757000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	32364000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4485000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4183000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	412258000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	318212000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	511940000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6083000	USD
CY2022Q1	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	871478000	USD
CY2021Q4	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	1394808000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1988047000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1986791000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	194867000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	188575000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	3572371000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	3972358000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	167000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1667597533	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1648413415	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1666739708	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1647555590	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	165000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9997176000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	186076000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	167369000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9995778000	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	857825	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	857825	shares
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	20716000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	20716000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6147158000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6065872000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3829469000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3909355000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7401840000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7881713000	USD
CY2022Q1	us-gaap	Revenues Revenues	57675000	USD
CY2021Q1	us-gaap	Revenues Revenues	313000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	245970000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	85000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	223159000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	131652000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	655205000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	299106000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-597530000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-298793000	USD
CY2022Q1	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	0	USD
CY2021Q1	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	442164000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	7705000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	5000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	942000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	516567000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-449155000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80963000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-747948000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	323000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-81286000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-81286000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-747952000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-747952000	USD
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2021Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167333000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-81286000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2915285000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1654322379	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1654322379	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32650874	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32650874	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-89.29
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-89.29
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3909355000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-81286000	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	182265000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9114000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	174551000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3829469000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	957159704	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2494076000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1318777000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-747952000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2167332000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4316000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1882000	USD
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1088999959	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	4454811000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-4227863000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-81286000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-747952000	USD
CY2022Q1	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	38242000	USD
CY2021Q1	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	4919000	USD
CY2022Q1	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	7499000	USD
CY2021Q1	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	0	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	4104000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	6296000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	174551000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	104795000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-56000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1255000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	96366000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2022Q1	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	0	USD
CY2021Q1	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	-442164000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2281000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	378000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	303022000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5267000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-20523000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3782000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	49625000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	544000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	11175000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2899000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5713000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-14544000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	298000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1201000	USD
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3607000	USD
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	3646000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3099000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4099000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	128060000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-11124000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1901000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3011000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-494649000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-218726000	USD
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	185082000	USD
CY2021Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	94779000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-185082000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94779000	USD
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	12949000	USD
CY2021Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9114000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4316000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	182265000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-187301000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	511098000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-867032000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	197593000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5430988000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	838011000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	312000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	57000	USD
CY2022Q1	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	-2753000	USD
CY2021Q1	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	-16357000	USD
CY2022Q1	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	10008000	USD
CY2021Q1	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	4073000	USD
CY2022Q1	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	0	USD
CY2021Q1	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	9936000	USD
CY2022Q1	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	0	USD
CY2021Q1	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	2167332000	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF BUSINESS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid Group, Inc. (“Lucid”) is a technology and automotive company focused on designing, developing, manufacturing, and selling the next generation of EV, EV powertrains and battery systems.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid was originally incorporated in Delaware on April 30, 2020 under the name Churchill Capital Corp IV (formerly known as Annetta Acquisition Corp) (“Churchill”) as a special purpose acquisition company with the purpose of effecting a merger with one or more operating businesses. On February 22, 2021, Churchill entered into a definitive merger agreement (the “Merger Agreement”) with Atieva, Inc. (“Legacy Lucid”) in which Legacy Lucid would become a wholly owned subsidiary of Churchill (the “Merger”). Upon the closing of the Merger on July 23, 2021 (the “Closing”), Churchill was immediately renamed to “Lucid Group, Inc.” The Merger between Churchill and Legacy Lucid was accounted for as a reverse recapitalization. See Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">– Reverse Recapitalization for more information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the notes to the condensed consolidated financial statements, unless otherwise noted, the “Company,” “we,” “us” or “our” and similar terms refer to Legacy Lucid and its subsidiaries prior to the consummation of the Merger, and Lucid and its subsidiaries after the consummation of the Merger.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company devotes its efforts to business planning, research and development, recruiting of management and technical staff, acquiring operating assets, and raising capital.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through March 31, 2022, the Company has incurred operating losses and negative cash flows from operating activities. For the three months ended March 31, 2022 and 2021, the Company has incurred operating losses, including net losses of $81.3 million and $748.0 million, respectively. The Company has an accumulated deficit of $6.1 billion as of March 31, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June 30, 2021, the Company completed the first phase of the construction of its newly built manufacturing plant in Casa Grande, Arizona (the “Arizona plant”). The Company began commercial production of its first vehicle, the Lucid Air, in September 2021 and delivered its first vehicles in late October 2021. The Company continues to expand the Arizona plant, start of construction of a manufacturing facility in the Kingdom of Saudi Arabia, and build-out of a network of retail sales and service locations. The Company has plans for continued development of additional vehicle model types for future release. The aforementioned activities will require considerable capital, above and beyond the expected cash inflows from the initial sales of the Lucid Air. As such, the future operating plan involves considerable risk if secure funding sources are not identified and confirmed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s existing sources of liquidity include cash and cash equivalents. Historically, the Company funded operations primarily with issuances of convertible preferred stock and convertible notes. Upon the completion of the Merger, the Company received $4,400.3 million in cash proceeds, net of transaction costs.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2021, the Company issued an aggregate of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2,012.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> principal amount of 1.25% convertible senior notes due in December 2026. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Significant Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s current business activities consist of research and development efforts to design and develop a high-performance fully electric vehicle and advanced electric vehicle powertrain components, including battery pack systems; building of the Company’s production operations in Casa Grande, Arizona; and build-out of the Company’s retail stores and service centers for distribution of the vehicles to customers. The Company is subject to the risks associated with such activities, including the need to further develop its technology, its marketing, and distribution channels; further develop its supply chain and manufacturing; and hire additional management and other key personnel. Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including our ability to access potential markets, and secure long-term financing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participates in a dynamic high-technology industry. Changes in any of the following areas could have a material adverse impact on the Company’s future financial position, results of operations, and/or cash flows: advances and trends in new technologies; competitive pressures; changes in the overall demand for its products and services; acceptance of the Company’s products and services; litigation or claims against the Company based on intellectual property, patent, regulatory, or other factors; and the Company’s ability to attract and retain employees necessary to support its growth.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to impact the global economy and cause significant macroeconomic uncertainty. Infection rates vary across the jurisdictions in which the Company operates. Governmental authorities have continued to implement numerous and constantly evolving measures to try to contain the virus, such as travel bans and restrictions, masking recommendations and mandates, vaccine recommendations and mandates, limits on gatherings, quarantines, shelter-in-place orders and business shutdowns. The Company has taken proactive action to protect the health and safety of its employees, customers, partners and suppliers, consistent with the latest and evolving governmental guidelines. The Company expects to continue to implement appropriate measures until the COVID-19 pandemic is adequately contained. The Company continues to monitor the rapidly evolving situation and guidance from international and domestic authorities, including federal, state and local public health authorities, and may take additional actions based on their recommendations and requirements or as the Company otherwise sees fit to protect the health and safety of its employees, customers, partners and suppliers.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While certain of the Company and its suppliers’ operations have from time-to-time been temporarily affected by government-mandated restrictions, the Company was able to commence deliveries of the Lucid Air to customers and to proceed with the construction of the Arizona plant. Broader impacts of the pandemic have included inflationary pressure as well as ongoing, industry-wide challenges in logistics and supply chains, such as increased port congestion, intermittent supplier delays and a shortfall of semiconductor supply. Because the Company relies on third party suppliers for the development, manufacture, and/or provision and development of many of the key components and materials used in its vehicles, as well as provisioning and servicing equipment in its manufacturing facilities, the Company has been affected by inflation and such industry-wide challenges in logistics and supply chains. While the Company continues to focus on mitigating risks to its operations and supply chain in the current industry environment, the Company expects that these industry-wide trends will continue to affect its cost structure as well as its ability and the ability of its suppliers to obtain parts, components and manufacturing equipment on a timely basis for the foreseeable future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current circumstances, given the dynamic nature of the situation, any impact on the Company’s financial condition, results of operations or cash flows in the future continues to be difficult to estimate and predict, as it depends on future events that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, the duration and continued spread of the outbreak, its severity, potential additional waves of infection, the emergence of more virulent or more dangerous strains of the virus, the actions taken to mitigate the virus or its impact, the development, distribution, efficacy and acceptance of vaccines worldwide, how quickly and to what extent normal economic and operating conditions can resume, the broader impact that the pandemic is having on the economy and our industry and specific implications the pandemic may have on the Company’s suppliers and on global logistics. See “Risk Factors” in Part II, Item 1A of this </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Report </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on Form 10-Q (the “Quarterly Report”) for additional information regarding risks associated with the COVID-19 pandemic, including under the caption “The ongoing COVID-19 pandemic has adversely affected, and we cannot predict its ultimate impact on, our business, results of operations and financial condition.”</span></div>
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-81300000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-748000000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6100000000	USD
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant estimates, assumptions and judgments made by management include, among others, inventory valuation, the determination of the useful lives of property and equipment, fair value of preferred stock warrants, fair value of common stock warrants, fair value of contingent forward contracts liability, valuation of deferred income tax assets and uncertain tax positions, fair value of common stock and other assumptions used to measure stock-based compensation expense, and estimated incremental borrowing rates for assessing operating and financing lease liabilities. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable </span></div>under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.
CY2022Q1	us-gaap	Cash Cash	5391844000	USD
CY2021Q4	us-gaap	Cash Cash	6262905000	USD
CY2021Q1	us-gaap	Cash Cash	809978000	USD
CY2020Q4	us-gaap	Cash Cash	614412000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	13312000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10740000	USD
CY2021Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	11790000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11278000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	25832000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	24375000	USD
CY2021Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	16243000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	14728000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5430988000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	838011000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	USD
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit RiskFinancial instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents, and accounts receivable. The Company places its cash primarily with domestic financial institutions that are federally insured within statutory limits, but at times its deposits may exceed federally insured limits. Further, accounts receivable primarily consists of current trade receivables from a single customer as of March 31, 2022 and December 31, 2021, which relates specifically to sales of its battery packs.
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	2.644
CY2021Q3	lcid	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments And Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsAndOptionsOutstandingNumber	42182931	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	437182072	shares
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	437182072	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	25764610	shares
CY2021Q3	lcid	Share Based Payment Award Options Converted ShareBasedPaymentAwardOptionsConverted	68121210	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	16418321	shares
CY2021Q3	lcid	Share Based Payment Award Non Option Equity Instruments Converted Reverse Recapitalization ShareBasedPaymentAwardNonOptionEquityInstrumentsConvertedReverseRecapitalization	43409870	shares
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	USD
CY2021Q3	lcid	Reverse Recapitalization Working Capital Loan Converted Amount ReverseRecapitalizationWorkingCapitalLoanConvertedAmount	1500000	USD
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1500000	shares
CY2021Q3	lcid	Debt Conversion Converted Instrument Warrants Or Options Issued Price Per Warrant DebtConversionConvertedInstrumentWarrantsOrOptionsIssuedPricePerWarrant	1.00
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Shares ReverseRecapitalizationContingentConsiderationShares	17250000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	lcid	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	1193226511	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	85750000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	4439200000	USD
CY2021Q3	lcid	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	2070100000	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	USD
CY2021Q3	us-gaap	Cash Cash	400000	USD
CY2021Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200000	USD
CY2021Q3	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	21644	shares
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Incurred ReverseRecapitalizationTransactionCostsIncurred	38900000	USD
CY2021Q3	lcid	Adjustments To Additional Paid In Capital Reduction For Reverse Recapitalization Transaction Costs AdjustmentsToAdditionalPaidInCapitalReductionForReverseRecapitalizationTransactionCosts	36200000	USD
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	2700000	USD
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	USD
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	234444000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	87646000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	43082000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	30641000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	56380000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8963000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	333906000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	127250000	USD
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	96400000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1451675000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1268166000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	124131000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	86013000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1327544000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1182153000	USD
CY2022Q1	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	38200000	USD
CY2021Q1	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	4900000	USD
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2022Q1	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	20251000	USD
CY2021Q4	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	33950000	USD
CY2022Q1	us-gaap	Construction Payable Current ConstructionPayableCurrent	97754000	USD
CY2021Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	92590000	USD
CY2022Q1	lcid	Accrued Unbilled Inventory Purchases AccruedUnbilledInventoryPurchases	98527000	USD
CY2021Q4	lcid	Accrued Unbilled Inventory Purchases AccruedUnbilledInventoryPurchases	12225000	USD
CY2022Q1	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	14888000	USD
CY2021Q4	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	15796000	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	23741000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	13944000	USD
CY2022Q1	lcid	Tooling Liability Current ToolingLiabilityCurrent	20866000	USD
CY2021Q4	lcid	Tooling Liability Current ToolingLiabilityCurrent	23966000	USD
CY2022Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	4399000	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	15281000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12448000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11056000	USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3000000	USD
CY2022Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	119384000	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	99404000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	412258000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	318212000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	189516000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	185323000	USD
CY2022Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	5351000	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3252000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	194867000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	188575000	USD
CY2021Q2	us-gaap	Share Price SharePrice	23.78
CY2017Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1546799	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2021Q1	lcid	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	12900000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q3	lcid	Number Of Milestone Conditions Required To Receive Funding NumberOfMilestoneConditionsRequiredToReceiveFunding	2	condition
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1316758889	shares
CY2021Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1155909398	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	lcid	Common Stock Voting Rights Number Of Votes Allowed For Each Share CommonStockVotingRightsNumberOfVotesAllowedForEachShare	1	vote
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised ClassOfWarrantOrRightNumberOfWarrantsExercised	41034197	shares
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised In Noncash Transaction ClassOfWarrantOrRightNumberOfWarrantsExercisedInNoncashTransaction	25966976	shares
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	173300000	USD
CY2021	lcid	Class Of Warrant Or Right Warrants Redeemed Or Called During Period Shares ClassOfWarrantOrRightWarrantsRedeemedOrCalledDuringPeriodShares	365803	shares
CY2021Q4	lcid	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.01
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	857825	shares
CY2021	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	24.15
CY2022Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	190805032	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	210204258	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Contingency Period ReverseRecapitalizationContingentConsiderationContingencyPeriod	P5Y
CY2021	lcid	Reverse Recapitalization Contingent Consideration Shares Vested ReverseRecapitalizationContingentConsiderationSharesVested	17250000	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdTradingDays	40	day
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdConsecutiveTradingDays	60	day
CY2021	lcid	Reverse Recapitalization Contingent Consideration Shares Vested ReverseRecapitalizationContingentConsiderationSharesVested	17250000	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.90
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12103110	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	64119902	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2370666000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.76
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1316554	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.60
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	50700238	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.14
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1231047000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	33233881	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M25D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	814996000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	48234611	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1615027	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	15108904	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	505116	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	34235618	shares
CY2022Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	8000000	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	174551000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	104795000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	166625000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161974000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12448000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11056000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	189516000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	185323000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	201964000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	196379000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10812000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10567000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10812000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10567000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4485000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4183000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6039000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6083000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	10524000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	10266000	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	9578000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	6303000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	778000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	580000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1096000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	615000	USD
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	145000	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	72000	USD
CY2022Q1	lcid	Finance Lease Cost FinanceLeaseCost	1241000	USD
CY2021Q1	lcid	Finance Lease Cost FinanceLeaseCost	687000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	11597000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	7570000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y9M18D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1062
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1098
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0567
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0558
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	23616000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	3708000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	39618000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4613000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	40076000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2012000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	39265000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	500000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	35545000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	362000	USD
CY2022Q1	lcid	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	135060000	USD
CY2022Q1	lcid	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	101000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	313180000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	11296000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	111216000	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	772000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	201964000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	10524000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12448000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4485000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	189516000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6039000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
CY2022Q1	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	45300000	USD
CY2022Q1	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	42900000	USD
CY2022Q1	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	49800000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
CY2022Q1	us-gaap	Purchase Obligation PurchaseObligation	138000000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-81286000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-747952000	USD
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2021Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167333000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-81286000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-81286000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2915285000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2915285000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1654322379	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1654322379	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32650874	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32650874	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-89.29
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-89.29
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	166023641	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	425270750	shares
CY2022Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2022Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2022Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2021Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD

Files In Submission

Name	View Source	Status
0001628280-22-012681-index-headers.html	Edgar Link	pending
0001628280-22-012681-index.html	Edgar Link	pending
0001628280-22-012681.txt	Edgar Link	pending
0001628280-22-012681-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lcid-20220331.htm	Edgar Link	pending
lcid-20220331.xsd	Edgar Link	pending
lcid-20220331_cal.xml	Edgar Link	unprocessable
lcid-20220331_def.xml	Edgar Link	unprocessable
lcid-20220331_htm.xml	Edgar Link	completed
lcid-20220331_lab.xml	Edgar Link	unprocessable
lcid-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
q12210q-ex101.htm	Edgar Link	pending
q12210q-ex102.htm	Edgar Link	pending
q12210q-ex103.htm	Edgar Link	pending
q12210q-ex311.htm	Edgar Link	pending
q12210q-ex312.htm	Edgar Link	pending
q12210q-ex321.htm	Edgar Link	pending
q12210q-ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LCID
Lucid Group, Inc. Stock $lcid

2022 Q1 Form 10-Q Financial Statement

#000162828022012681 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID Lucid Group, Inc. Stock $lcid

2022 Q1 Form 10-Q Financial Statement

#000162828022012681 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID
Lucid Group, Inc. Stock $lcid